Drug Shortage Report for CYSTADROPS
| Report ID | 109255 |
| Drug Identification Number | 02485605 |
| Brand name | CYSTADROPS |
| Common or Proper name | Cysteamine solution |
| Company Name | RECORDATI RARE DISEASES CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CYSTEAMINE |
| Strength(s) | 0.37% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | one vial |
| ATC code | S01XA |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-03-20 |
| Estimated end date | 2020-04-20 |
| Actual end date | 2020-04-14 |
| Shortage status | Resolved |
| Updated date | 2020-04-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3080 YONGE STREET, SUITE 6060 TORONTO, ONTARIO CANADA M4N 3N1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-04-20 | French | Compare |
| v3 | 2020-04-20 | English | Compare |
| v2 | 2020-03-23 | French | Compare |
| v1 | 2020-03-23 | English | Compare |
Showing 1 to 4 of 4